Memorial Sloan-Kettering Cancer Center Inc.

Dr. Cassileth is currently the Chief of the Integrative Medicine Service at Memorial Sloan-Kettering Cancer Center, as well as an Attending there. She is also a Consulting Professor in Community and Family Medicine at Duke University Medical Center, an Adjunct Professor of Medicine (Oncology) at University of North Carolina at Chapel Hill, and a Visiting Lecturer in Medicine at Harvard University. Over the years, Dr. Cassileth has held key positions with numerous national organizations, including the National Institutes of Health, the National Cancer Institute, and the American Cancer Society. She is on the Board of Directors of the American Cancer Society and a member of the Public Issues Committee and the American Society of Clinical Oncology. Dr. Cassileth has authored hundreds of original papers and articles on the psychosocial aspects of cancer for leading general and specialty journals, including such topics as: the role of patient participation in therapeutic decision making, quality of life issues for cancer patients, and patient care during the terminal phase of illness. She has also written extensively for both the scientific and lay press on the topic of alternative and complementary therapies. She is a member of the Editorial and Advisory Boards for several prominent journals, including Cancer, FACT (Focus on Alternative Cancer Therapies), The Hospice Journal, Oncology, Oncology News International, and Journal of Psychosocial Oncology. She also reviews articles for numerous primary care and specialty journals, including the New England Journal of Medicine, the Journal of the American Medical Association, and the Journal of Clinical Oncology. Because of her expertise, Dr. Cassileth has been invited to lecture at medical schools and conferences throughout the United States and the world. She is recognized as an expert in alternative and complementary medicine and the psychosocial aspects of cancer. Dr. Cassileth's educational background includes a B.A. from Bennington College in Vermont and a M.S. in Psychology from Albert Einstein in New York, followed a doctorate in Medical Sociology at the University of Pennsylvania.

Dr. Eric Pamer is Chief of the Infectious Diseases Service at Memorial Sloan-Kettering Cancer Center and holds the Enid A. Haupt Chair in Clinical Investigation. He was the recipient of an NIH Clinical Investigator Award and an Arthritis Investigator Award. He was a Smith-Kline Beecham Young Investigator and a Pew Scholar in the Biomedical Sciences in 1994.

Dr. Larry Norton is Deputy Physician-in-Chief and Director of Breast Cancer Programs at Memorial Sloan-Kettering Cancer Center in New York City. He also serves as Medical Director of MSK 64th Street, comprised of the Evelyn H. Lauder Breast Center and the Iris Cantor Diagnostic Center. He is the principal investigator of a Program Project Grant from the National Cancer Institute, which is aimed at better understanding breast cancer in the laboratory and in bringing these advances into clinical practice. On a national level, Dr. Norton has served as Chair of the Breast Committee of the National Cancer Institute's Cancer and Leukemia Group B, and is President of the National Alliance of Breast Cancer Organizations (NABCO). He is past President of the American Society of Clinical Oncology, and was appointed by President Clinton to the National Cancer Advisory Board of the NCI. After receiving his M.D. from the College of Physicians and Surgeons, Columbia University, he trained in Internal Medicine at the Albert Einstein College of Medicine. He then served as a Clinical Associate and Investigator at the NCI prior to joining the faculty of the Mount Sinai Medical Center in New York from 1977 to 1988. He is currently Professor of Medicine, Weill Medical College of Cornell University.

Dr. Martin Fleisher is Chair, Department of Clinical Laboratories and Chief, Clinical Chemistry Service at Memorial Sloan-Kettering Cancer Center. He is a widely known clinical chemist who is an expert in the areas of tumor markers, critical care laboratory medicine, laboratory automation and robotics, and specific protein analysis in B-cell dyscrasia. He is known for his contributions validating tumor markers and biomarkers for early detection of ovarian cancer and for monitoring how prostate cancer patients respond to treatment. He and his colleagues have also devised tests for estimating breast cancer risk and detecting metastases near the brain. Dr. Fleisher is the author of more than 130 publications and holds five US patent

Dr. Nimer is Professor of Medicine and Professor of Pharmacology at Weill Medical College of Cornell University. He also serves as Chief of Hematology Service and Head of the Division of Hematologic Oncology at Memorial Sloan-Kettering Cancer Center in New York City. Dr. Nimer is a member of many national professional organizations, including the American Society of Hematology, the American Society of Clinical Oncology, and the International Society for Stem Cell Research. He serves as a Reviewer for major medical journals, including the New England Journal of Medicine and the Journal of the American Medical Association (JAMA) among many others. He serves on numerous national and international Grant Review Committees and is a prominent invited speaker at conferences on his areas of expertise. He has authored or co-authored nearly 200 peer-reviewed papers, reviews, editorials and textbook chapters, primarily focused on issues concerning hematology and oncology

Dr. Elisa Weiss is a medical sociologist and Director of Operations of the Research Program in Community Outreach and Health Disparities at Memorial Sloan-Kettering Cancer Center. Her research has focused on creating new conceptual models and methodologies for evaluating the functioning of inter-organizational and academic-community partnerships, and for demonstrating the value of partnership work in addressing complex public health problems. Dr. Weiss is presently Co-investigator and Project Director of an NCI-sponsored participatory research study that is utilizing the Queens Borough Public Library system and community coalitions to foster access to cancer detection and preventive care in medically underserved communities. She was recently the partnership evaluator for a federally-funded CBPR project to address teen health disparities in the Bronx and for Team Up: Cancer Screening Saves Lives, a national collaborative project of the NCI, ACS, CDC, and USDA that was carried out in six Southern states to increase breast and cervical cancer screening rates among rarely or never screened women. In addition, Dr. Weiss is the PI of a multi-institutional pilot study in New York City that examines the socio-economic impact of colon cancer among low-income cancer survivors age 65 and older, in order to identify unmet resource and service needs. She is also the Co-PI of a study recently funded by the NCI that will, in collaboration with ENACCT, explore primary care physicians? attitudes towards cancer clinical trials and their referral patterns for low-income cancer patients in New York City; the study will use these data to adapt and test ENACCT?s cancer clinical trials education training for primary care physicians. Dr. Weiss received her doctorate in sociology from Columbia University.

Fayez S. Sarofim, 80 , has been a director of the Company since March 1990. He has been Chairman of the Board and President of Fayez Sarofim & Co., a registered investment advisor, for more than five years. He is also a director of Argo Group International Holdings, Ltd., an international underwriter of specialty insurance and reinsurance products in the property and casualty market.

Dr. Freeman is the Medical Director of The Ralph Lauren Center for Cancer Care and Prevention in New York City. He is also the Associate Director of the National Cancer Institute (NCI) and Director of the NCI Center to Reduce Cancer Health Disparities. He also served as Director of Surgery at North General Hospital in New York City. He holds the academic position of Professor of Clinical Surgery at Columbia University College of Physicians and Surgeons. Dr. Freeman is a Clinical Affiliate Attending, Department of Surgery, in the Breast Service at Memorial Sloan-Kettering Cancer Center. He held the position of Director of Surgery at Harlem Hospital for twenty-five years (1974-1999). He served as President and CEO of North General Hospital, NYC, for a two-year period ending in 2001. Dr. Freeman is a Diplomat of the American Board of Surgery and a Fellow of the American College of Surgeons. Dr. Freeman served as a member of the Executive Committee of the Board of Governors of the American College of Surgeons. Dr. Freeman served on the Executive Council of the Society of Surgical Oncology. He has been Medical Director of the Breast Examination Center of Harlem, a program of Memorial Sloan-Kettering Cancer Center, since 1979. Dr. Freeman is past Chairman of the United States President's Cancer Panel. He has been appointed to this position for four three-year terms, first by President Bush in 1991 and subsequently by President Clinton in 1994, 1997 and 2000. Dr. Freeman is the chief architect of the American Cancer Society's initiative on cancer in the poor and is a leading authority on the interrelationships between race, poverty and cancer. Related to this, the "Harold P. Freeman Award" was established by the American Cancer Society in 1990. This award may be given annually in ACS divisions throughout America to individuals who have made outstanding contributions in the fight against cancer in the poor. Dr. Freeman served as National President of the American Cancer Society from 1988-1989. Selected awards received by Dr. Freeman are: Mary Lasker Award for Public Service, Time, Inc. Health Lifetime Achievement Award, The American Cancer Society Medal of Honor, The 2001 CDC Champion of Prevention Award from the Centers for Disease Control on the occasion of their 50th anniversary and the 2002 Breast Cancer Research Foundation "Jill Rose Award." Dr. Freeman was elected to membership in the Institute of Medicine of the National Academy of Sciences in 1997. On May 31, 2003, Dr. Freeman received a Special Recognition Award from the American Society of Clinical Oncology (ASCO). This award recognizes a person or persons who have had a major impact in areas of clinical oncology, cancer research, clinical trials, reimbursement and patient advocacy.

A leading researcher in the area of male sexual health, Dr. Mulhall is Director of Male Sexual and Reproductive Medicine at Memorial Sloan-Kettering Cancer Center in New York.

John Thomas Pinto, Ph.D., is the director of the Nutrition Research Laboratory and co-director of the Metabolism and Oncology Core Laboratory at Memorial Sloan-Kettering Cancer Center. He received his undergraduate degree from St. John Fisher College in Rochester, New York, and his Ph.D. in biochemistry from the University of Medicine and Dentistry of New Jersey. Pinto has been an assistant professor at New York Medical College and an associate professor at Cornell University Medical College and the University of Bridgeport. Pinto serves as associate program director of the Clinical Nutrition Research Unit, granted by the National Cancer Institute to provide nutrition education and training in cancer research at Memorial Sloan-Kettering Cancer Center, Cornell University Medical College and Rockefeller University. He is currently investigating chemopreventive agents and the metabolic effects of drugs and vitamin deprivation upon cell membrane integrity and receptor function, and the intracellular oxidative stress imposed on breast and prostate carcinoma cells by drugs and radiation.

Dr. Nancy A. Kernan is the Assistant Chief of the Bone Marrow Transplant Service and Director of the Unrelated Donor Program at Memorial Sloan-Kettering Cancer Center in New York City. Dr. Kernan is the immediate past Chairperson of the board of directors of the National Marrow Donor Program (NMDP). She also serves as Associate Attending Pediatrician at New York Hospital, Associate Professor of Pediatrics at Cornell University and Attending Pediatrician at Memorial Hospital. Kernan was responsible for the retrospective review of the first 462 patients to receive marrow from an unrelated donor facilitated through the NMDP. Kernan received her Doctor of Medicine from Cornell University Medical College in New York.

David Gorman is the Business Manager for Radiology at Memorial Sloan Kettering Cancer Center in New York. Working at Sloan for almost 20 years and in radiology for six years, he is responsible for all of the radiology business services with the hospital and all of the satellite sites in New York City, Long Island and New Jersey. These services include billing, compliance, transcription, coding and scheduling as well as oversight for clinical research in Radiology. David has spent the last 27 years in healthcare, serving in various capacities in pharmacy, nursing and ambulatory care and finally, radiology.

Fabienne Volel is a manager at Memorial Sloan-Kettering Cancer Center. She is currently a graduate student at NYU pursuing her Masters degree in Nutrition. Fabienne has hosted numerous seminars and workshops focused on dietetics and healthy lifestyle modifications for various universities, churches and organizations. In addition, she conducts personal consultations in nutrition. Fabie (as she is affectionately called) is passionate about healthy living due to her experience of losing her mother to heart disease. She desires to see a better, healthier world. Fabie's other pursuits include, writing recipes for a publication entitled "Pickled: Vegetables-Fruits-Roots-More: Preserving a World of Tastes and Traditions," by Lucy Norris; compiling her bible study lessons into books; and doing mission work in Israel, Egypt, and Bosnia. Due to Fabie's vast and varied experiences she serves as a valuable and pragmatic counselor to the organization. Her desire to minister to children and young adult women without mothers like herself resonates with one of the assignments D.O.V.E. is exploring.

Adam Cohen holds a BA in English from the University of Pennsylvania and a JD from the Duke University School of Law. After working as a litigator for the law firm of Hughes Hubbard & Reed in New York, where he specialized in products liability defense for such clients as Merck and Chrysler (now DaimlerChrysler), he came to Oklahoma in 1997 to serve as law clerk to the Honorable Robert H. Henry of the U.S. Court of Appeals for the 10th Circuit. Following his clerkship, Cohen served as a staff attorney for the University of Oklahoma, focusing on employment litigation, and also worked as a freelance writer. His articles appeared in more than a dozen publications, including The American Lawyer, Men's Journal, The Dallas Morning News and the Los Angeles Times, and he also wrote news copy for the Oklahoma City NBC affiliate, KFOR TV. In 2001, Cohen won the Dallas Press Club's Katie Award for his feature writing. Since joining OMRF in 2002, he has continued to put his skills both as a journalist and an attorney to use. During this time, OMRF's Department of Public Affairs has earned more than 15 top prizes in journalism and public relations competitions, and Cohen has been recognized as an "Achiever under 40" by The Journal Record newspaper and as a member of the OKC Business "Forty under 40."

Catherine Hydzik is a Clinical Nurse Specialist at Memorial Sloan Kettering Cancer Center, specializing in Ambulatory Chemotherapy. She received a Master's Degree in Nursing from Adelphi University in Garden City, New York. Catherine completed 2 Post Master's Certificate Programs, one in Oncology Nursing and the other in the Adult Nurse Practitioner Program. She is a certified ONS Cancer Chemotherapy and Biotherapy Trainer and has earned a certification as an Advanced Oncology Certified Nurse. Catherine's 30 years in nursing have included roles as staff nurse, assistant head nurse, head nurse, oncology nurse, clinical nurse specialist and educator. She has presented and published on the subject of chemotherapy. Catherine is a member of the Oncology Nursing Society and the Chemotherapy Special Interest Group.

David P. Kelsen, M.D. has served as a director of Response Genetics since March 2000. Dr. Kelsen has been a Professor of Medicine at Cornell University Medical College since 1992, an attending physician at Memorial Hospital for Cancer and Allied Diseases since 1991, and has held numerous hospital and administrative positions at Memorial Sloan-Kettering Cancer Center since 1980, including among others the current position of Chief, Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine. Dr. Kelsen received his M.D. from Hahnemann Medical College and a B.A. from Temple University.

Dean F. Bajorin, MD, FACP is Professor of Medicine at Memorial Sloan-Kettering Cancer Center and the Weill. Medical College of Cornell University in New York. He is also Program Director for the Fellowship in. Medical. Oncology/Hematology and Director of the Clinical Research Curriculum for training clinical investigators at Memorial Sloan- Kettering Cancer Center. Dr. Bajorin earned his medical degree at New York Medical College. He completed his internship and residency at Hartford. Hospital in Connecticut and an oncology research fellowship at Memorial Sloan-Kettering Cancer Center.

Edward Lenard, a 1996 graduate of Maritime College, served as the top assistant coach for the men's basketball team for two seasons before taking over head coaching duties in December of 2006. Lenard, who earned a bachelor of science in Facilities Engineering, currently works as the Manager of Plant Operations at the Memorial Sloan-Kettering Cancer Center in Manhattan. During his time as an undergrad, Lenard was a member of the Privateer basketball team for three seasons.

Elizabeth T. Peabody, LMSW, has been associated with Memorial Sloan-Kettering Cancer Center for 16 years, working closely with Dr. Jimmie Holland in the Department of Psychiatry. For the last 10 years much of her work has focused on the psychosocial issues faced by those diagnosed with lung cancer and/or COPD (chronic obstructive pulmonary disease). She is also affiliated with the Maria Droste Services, which offers psychotherapy to those who have no medical insurance. Ms. Peabody received her MSW from the Fordham School of Social Work.

Gillian M. Shepherd, MD is a specialist in Allergy and Immunology. She is a Clinical Associate Professor of Medicine at Weill Medical College of Cornell University and is an Attending at New York Presbyterian Hospital as well as a Consultant in Clinical Immunology at Memorial Sloan Kettering Cancer Center. After graduating from New York Medical College, she completed a residency in Allergy and Immunology at the New York Hospital-Cornell Medical Center. For the next fourteen years, she was on the full-time faculty at Cornell, directing the Allergy-Immunology Clinical Service. In 1995 she moved her clinical practice to a private office but continues to teach actively at Cornell and nationally. She has received four national teaching awards from the American College of Physicians and she is listed in America's Top Doctors (less than 1% of US M.D.'s) and in every edition of New York Magazine's Best Doctors. Dr. Shepherd has been very involved with the American Academy of Allergy Asthma and Immunology, the main international organization for her specialty. She is on the Board of Directors and chairs several committees, including oversight of all educational activities of the organization, the annual meeting and redesign of the web site. She was first elected chair of the Education and Research Trust, which awards grants to support her specialty. She is also past President of the New York Allergy Society.

Array

A native of Fairbanks, Alaska, Isaac Krauss has been a member of the Park Avenue Chamber Symphony since 2002. At age 5, he was encouraged to begin study of the violin and later the piano, two instruments for which he formed a life-long passion. His first influential music teacher was Kathleen Butler-Hopkins of the University of Alaska. Other formative musical experiences included a half year of study in Leningrad, USSR in 1990 with Lev Alexandrovich Ivashenko at the Pre-Conservatory School, as well as several summers studying with Linda Cerone at ENCORE School for Strings, near Cleveland. At the end of high school Mr. Krauss decided to attend Stanford University rather than continue along the path of professional musical training. There he actively continued violin studies under the tutelage of Phillip Levy. He also pursued extensively his interest in chamber music. In academic studies, his favorite subjects included the Russian and Japanese languages, English literature and chemistry. After receiving his B. A. in chemistry in 1998, he continued with graduate work, obtaining his Ph. D. from Columbia University in August 2003. Mr. Krauss now works as a postdoctoral research fellow at Memorial Sloan Kettering Cancer Center and hopes eventually to continue his career as a professor at a major university.

Jeffrey Forman, MD, FACR is board certified in therapeutic radiology by the American Board of Radiology. He earned his medical degree from New York University School of Medicine. He completed his medical internship, residency and fellowship in Radiation Oncology at Johns Hopkins Hospital in Baltimore Maryland. Dr. Forman has held faculty appointments at Wayne State University, where he was chairman, The University of Michigan, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College. Prior to joining 21st Century Oncology as the medical director of the Michigan Region, Dr. Forman was the medical director of affiliate programs and satellites for the Karmanos Cancer Institute. Dr. Forman is significantly involved in his professional societies, which include ASTRO, ASCO, ACS, and RTOG and was the past chairman of radiation oncology and the OA Center for SWOG. He has been awarded numerous honors and awards which include the James E. Constantine Award, Teacher of the Year at Memorial Sloan-Kettering Cancer Center, Best Doctors in America (1994, 1996, 1998, 2002, and 2004), Jewish National Foundation Tree of Life Award, Fellow of American College of Radiology, Israeli Cancer Association Award and the American Cancer Society Lane Adams Award. Dr. Forman has been the principal investigator of 12 grants, and has authored more than 150 publications, 8 book chapters, and 116 abstracts. He has presented nationally, as well as internationally, regarding his work on cancer especially his work on prostate cancer. He has coauthored the 2007 NOA and AUA Guidelines for the Treatment of Prostate Cancer.

Jimmie C. Holland, MD, is an attending psychiatrist at Memorial Sloan-Kettering Cancer Center in New York City and a professor of psychiatry at Weill Medical College of Cornell University, also in New York City. Holland is recognized as the founder of the subspecialty of psycho-oncology. Starting in the mid-1970s, she conducted some of the first epidemiologic studies related to the prevalence and nature of psychological problems in patients with cancer.

Jonine Bernstein, Ph.D., M.S. is an Associate Attending Epidemiologist at the Memorial Sloan-Kettering Cancer Center in New York City. She is also an Adjunct Associate Professor in both the Departments of Community and Preventive Medicine and the Department of Oncologic Sciences at the Mount Sinai School of Medicine in New York City. Background: Dr. Bernstein holds a Ph.D. in Epidemiology from Yale University, an M.S. in Applied Biometry from the University of Southern California, and an A.B. from Brown University. Her research has focused on understanding the joint roles of environmental exposures and genetic susceptibility in the etiology of cancer. She is currently involved in etiologic studies examining the roles of ATM, BRCA1/2, CHEK2, and other DNA repair genes in breast cancer. In addition, Dr. Bernstein is working on projects developing and validating biomarkers of disease. The common goal of all of these projects is to identify women at highest risk because of gene carrier status, environmental exposures, or a combination of both. To help carry out these studies, Dr. Bernstein has spear-headed an international multi-disciplinary consortium involving over 25 institutions in the US and abroad. She serves as a standing member of the NIH review group EPIC and has served as an ad hoc reviewer on over 20 reviews for the NIH, DOD, and VA. In addition to her work as the Chair of the ACE Membership Committee, she has served on numerous committees for the American Association of Cancer Research (AACR), and has organized scientific symposia for AACR, SER, and ISEE. Dr. Bernstein was co-founder and co-Chair of the mentoring program at Mount Sinai Hospital in NYC and elected Board member of the Woman's Faculty Group.

Kathleen M. Foley is one of the world's leading authorities in cancer pain management and palliative care. Her research focuses on the use of analgesic drugs to relieve cancer pain. Kathleen was the founding director of the Project on Death in America, which funded initiatives to improve the care of the dying. Kathleen is currently an attending neurologist at Memorial Sloan-Kettering Cancer Center.

Array

Brother Miguel A. Pina Jr. is a graduate of the University of Rochester in Rochester, New York where he earned a Bachelor of Arts in Health and Society (Public Health). He has been accepted into The College of Mount Saint Vincent's Second Degree Program for Nursing which is located in Riverdale, New York. Brother Pina's ultimate goal is to become a Certified Registered Nurse Anesthetists. In efforts to pursue his dream Brother Pina works at Memorial Sloan Kettering Cancer Center. Brother Pina was initiated into Kappa Alpha Psi through the New Rochelle-White Plains Alumni Chapter on April 15th 2005- 6 Knights of Kamelot. Brother Pina is a determined individual that believes through one's achievement and a positive form of guidance many lives can be touched. In joining the Bond, Brother Pina has accepted positions as Lt. Strategus and assisting with the current Keeper of Exchequer.

Mr. Selby serves as Senior Managing Director, for Perseus LLC. He has lead responsibility for Perseus' strategy and investments in the pharmaceutical, biotechnology, and medical products industries. Mr. Selby was formerly President and CEO of TransForm Pharmaceuticals, a specialty pharmaceutical company focused on innovation in the form and formulation of drug compounds that was acquired by Johnson & Johnson in April 2005. Prior to that, Mr. Selby was a Senior Officer at Citigroup/Citicorp, which he joined as Executive Vice President and head of Global Audit and Risk Review, and was a member of the Citicorp Management Committee. Mr. Selby was also a Director (Senior Partner) in the New York office of McKinsey & Company. In his 18 years at McKinsey, Mr. Selby's work concentrated on strategy and organization issues for a variety of companies in the healthcare, consumer, communications, and manufacturing industries. He held several leadership roles at McKinsey, including head of the firm's Global Pharmaceuticals Practice, head of the New York office's Healthcare and Consumer Industry Practices, and member of the firm's Principals Committee. From 1987 to 1989, Mr. Selby took a leave of absence from McKinsey to serve as Chief Operating Officer of the New York Blood Center, the largest community blood organization in the country, where he led its financial and operational turnaround. He is a member of the Board of Directors of Millennium Pharmaceuticals (MLNM), Medsite, Inc., Perseus Books, L.L.C., and NanoBio Corporation. He is also Chairman of Windhover Information, the leading B2B publishing and information company in the pharmaceutical, biotechnology, and medical device industries. Mr. Selby serves on the Board of Trustees of the Central Park Conservancy and the Memorial Sloan-Kettering Cancer Center, is a board member of the Ralph Lauren Center for Cancer Care and Prevention in Harlem, and is an advisory board member of Harvard Business School's Healthcare Initiative.

Owen A. O'Connor, MD, PhD is an Attending Physician in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York, where he is the Head of the Laboratory of Experimental Therapeutics for the Lymphoproliferative Malignancies. His research interests focus on the discovery and development of novel small molecules for the treatment of hematologic malignancies. Dr. O'Connor received his Ph.D. from the New York University School of Medicine in Biochemical Toxicology and Chemical Carcinogenesis, and his M.D. from the University of Medicine and Dentistry of New Jersey. He then went on to do a medical internship and residency at the The New York Hospital-Cornell University Medical Center. Following his medical residency, he did a fellowship in Medical Oncology at the Memorial Sloan Kettering Cancer Center, and a Fellowship in Clinical Pharmacology at the New York Hospital-Cornell University Medical School. During his fellowship, he worked in the laboratory of Dr. Joseph R. Bertino. Dr. O'Connors research interests focus on the discovery of novel small molecules for the treatment of non-Hodgkin's lymphoma and Hodgkin's disease using unique animal models of lymphoma and high-throughput screening approaches. Clinically, he is focused on the conduct of several Phase I and II clinical trials, with a particular interest in the development of proteasome inhibitors and histone deacetylase inhibitors for the treatment of hematologic malignancies. Dr. O'Connor is a member of several professional societies, including the American Association for Cancer Research, the American Society for Clinical Oncology, the American Society for Hematology. He serves on the Lymphoma Committee for the CALGB, and is a member of the Executive Committee for the Mantle Cell Lymphoma Consortium for the Lymphoma Research Foundation. He has published dozens of articles in numerous journals, including, but not limited to, Proceedings of the National Academy of Science, Journal of Clinical Oncology, Leukemia and Lymphoma, and Clinical Cancer Research, Environmental Science and Technology and Environmental Toxicology and Chemistry. His research has resulted in numerous abstracts of papers presented at National and International meetings. He is also the recipient of several honors and awards, including the Scholar in Clinical Research Award from the Leukemia and Lymphoma Society, a Merit Award from the American Society for Clinical Oncology, and the William Guy Forbeck Scholar Award.

Array

Array

Dr. Sogani is a professor of clinical urology at Weill Medical College of Cornell University and an attending surgeon at Memorial Sloan-Kettering Cancer Center in New York. He has served as treasurer and president of the New York Section of the AUA and is a member of 25 national and international medical societies. He is a fellow of American College of Surgeons and Royal College of Physicians and Surgeons of Canada, as well as the recipient of the 2006 John K. Lattimer Award of Excellence in Urology. He has authored more than 100 peer-reviewed articles and many book chapters. He is a past recipient of the Sasruta Award of Excellence in Urology of the Indian American Urological Association. Dr. Sogani earned his medical degree from MGM Medical College in India and has been a member of the AUA since 1983.

Array

Mr. Lamont brings over 30 years of broad based Information Technology experience from the private sector to the MSA management team. Mr. Lamont has held technical and management positions at Fortune 500 companies such as New York Life Insurance Company and Lehman Brothers Inc, as well as at Memorial Sloan-Kettering Cancer Center, and Brown Brothers Harriman, a private bank. During his career Robert has been responsible for the development of mission critical business applications, multi-platform system software integration, enterprise computing, and Business Continuity Planning. Robert holds a bachelor?s degree in Computer Science from St. John?s University and has professional certifications as a Certified Business Continuity Professional, (CBCP), and a Certified Information System Security Professional (CISSP).

Sonia is a neuroscientist specialized in brain cancer research, a science writer and author. At Memorial Sloan Kettering Cancer Center, in NYC, she is currently on a team that translates scientific discoveries into clinical trials in humans. She is also a certified Instructor in Hatha, Kundalini and Naam Yoga, teaching since 1997, and a practitioner of Harmonyum Healing. Having served briefly as Executive Director of Universal Force, Inc., home of Naam Yoga, founded by Master Joseph Michael Levry, she has embarked on yet a new journey at the interface of science and spirituality: she is studying the physiological effects of these ancient practices on a multi-disciplinary project aimed to integrate spiritual and physical therapy with conventional medicine.

Vincent A. Miller, MD, is an Associate Attending Physician on the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center and Associate Professor of Medicine at Weill Medical College of Cornell University. Dr. Miller?s main research focus is on drug development and the treatment of non?small cell lung carcinoma. His initial work was central to the approval of bexarotene in CTCL and docetaxel in NSCLC. More recently, Dr. Miller has been a leader in the development of therapies targeted at the HER family of receptors. His collaborative work has been central to gaining an understanding of the clinical and molecular predictors of sensitivity and resistance to erlotinib and gefitinib in NSCLC. Dr. Miller has received both the prestigious American Cancer Society Clinical Oncology Career Development Award and the Louise and Allston Boyer Award. Dr. Miller currently serves as a Track Leader in Lung Cancer for the ASCO Cancer Education Committee. Dr. Miller earned a BS in Mathematics at the University of Pennsylvania where he was honored as a Benjamin Franklin Scholar and then received his M.D. at the University of Medicine and Dentistry of New Jersey in Newark. He completed an internship and residency and then served as Chief Medical Resident in Internal Medicine at Thomas Jefferson University Hospital in Philadelphia, and subsequently a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center.

William C. Steere, Jr. has been the Chairman Emeritus of Pfizer Inc. since July 2001. He has been a director of Pfizer Inc. since 1987, was Chairman of the Board from 1992 to April 2001 and was Chief Executive Officer from February 1991 to December 2000. Mr. Steere also serves on the boards of directors of MetLife, Inc., the New York University Medical Center, The New York Botanical Garden, the Naples Symphony and the Board of Overseers of Memorial Sloan-Kettering Cancer Center.

Willibald Nagler, M.D., a native of Austria, received his M.D. degree in 1958 from the Medical School at the University of Vienna. He received graduate training at theHospital for Special Surgery and The New York Hospital-Cornell University Medical Center. Since 1971, he has held the position of Professor of Rehabilitation Medicine at Cornell University Medical College as well as Physiatrist-in-Chief and Residency Program Director of the Department of Rehabilitation Medicine at The New York Hospital-Cornell Medical Center. Dr. Nagler is also a consultant at Memorial Sloan-Kettering Cancer Center and a member of the Advisory Board for Rehabilitation Medicine at the Hospital for Special Surgery. His patients have included the late President John F. Kennedy, many famous musicians, sports figures and business leaders. Dr. Nagler, a sought after medical authority and lecturer, has received many honors for his outstanding medical work including in 1985 an endowed Chair as the Jerome and Anne Fisher Physiatrist-in-Chief at The New York Hospital-Cornell Medical Center. In 1990, he received the American Congress of Rehabilitation Medicine's Conrad Jobst Award for outstanding contributions in vascular research. He ist past President of the PM&R section of the Pan American Medical Association. Dr. Nagler has appeared on national television, authored numerous articels in medical journals and received acclaim for his popular book, "Dr. Nagler's Body Maintenance and Repair Book". Dr. Nagler has special interest in the non-surgical treatment of lumbar spine disorders and conducts an investigative program in the rehabilitation of burned children and of cerebral vascular disorders.

Dr. Sawyers is Chairman of Memorial Sloan-Kettering Cancer Center's Human Oncology and Pathogenesis Program (HOPP) and the first incumbent of the Marie Josee and Henry R. Kravis Chair. HOPP capitalizes on recent advances in understanding cancer cell biology and the development of molecularly targeted drugs and other rationally based interventions. It brings together physician-scientists from various clinical and scientific disciplines to conduct cutting-edge translational research across many types of cancer. Dr. Sawyers' work examines how signaling pathway abnormalities in cancer cells can be exploited as targets for new cancer drugs. The promise of this approach is best exemplified by Dr. Sawyers' key role in the clinical development of imatinib (Gleevec ), which targets the molecular cause of chronic myeloid leukemia (CML) with minimal side effects. His group subsequently deciphered the molecular basis for resistance to imatinib. Based on this insight, he led the development of a second drug called dasatinib, which is effective in CML patients whose disease fails to respond to imatinib. He has extended this approach to other diseases, including prostate cancer and glioblastoma, through laboratory-based studies that suggest new treatment strategies now undergoing clinical testing. Dr. Sawyers came to Memorial Sloan-Kettering after nearly two decades at the University of California, Los Angeles (UCLA). He received his undergraduate degree from Princeton University and his medical degree from The Johns Hopkins University. He completed a residency in internal medicine at the University of California, San Francisco, Medical Center and a clinical fellowship in hematology/oncology at the UCLA School of Medicine. He is also a Howard Hughes Medical Institute Investigator. His awards include the Doris Duke Distinguished Clinical Scientist Award, the Richard and Hinda Rosenthal Foundation Award, and the David A. Karnofsky Award.